Biocept Inc (NASDAQ:BIOC)

0.8985
Delayed Data
As of Aug 14
 -0.1115 / -11.04%
Today’s Change
0.21
Today|||52-Week Range
1.30
+214.16%
Year-to-Date
Biocept to provide COVID-19 testing to multi-state locations
Aug 13 / Seeking Alpha - Paid Partner Content
Biocept EPS in-line, misses on revenue
Aug 12 / Seeking Alpha - Paid Partner Content
Biocept, Inc. (BIOC) CEO Michael Nall on Q2 2020 Results - Earnings Call Transcript
Aug 12 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close1.01
Today’s open1.02
Day’s range0.86 - 1.02
Volume945,217
Average volume (3 months)27,174,590
Market cap$131.1M
Data as of 4:14pm ET, 08/14/2020

Growth & Valuation

Earnings growth (last year)+86.43%
Earnings growth (this year)+82.38%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+70.09%
P/E ratioNM
Price/Sales1.07
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
FORRForrester Research I...-0.01-0.03%
NRCNational Research Co...-1.48-2.60%
Data as of 3:59pm ET, 08/14/2020

Financials

Next reporting dateNovember 5, 2020
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$5.5M
Annual profit (last year)-$25.1M
Net profit margin-454.69%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
No executives to display
Corporate headquarters
San Diego, California

Forecasts